A PROOF OF CONCEPT STUDY TO EVALUATE THE ANTIVIRAL ACTIVITY, SAFETY, AND PHARMACOKINETICS OF THE CCR5 ANTAGONIST TBR 652 IN HIV 1-INFECTED, ANTIRETROVIRAL TREATMENT-EXPERIENCED, CCR5 ANTAGONIST-NAÏVE PATIENTS: